“Lovenox (enoxaparin sodium) therapy appears to be safe and efficacious for pregnant women who are candidates for either ...

Twenty-eight obese patients were given once-daily doses of 0.5 mg/kg of enoxaparin sodium, and anti-factor Xa levels were determined after the first or second dose. The investigators found that ...

At the end of July, the FDA granted marketing approval to an anticoagulant, the low-molecular-weight heparin (LMWH) enoxaparin sodium injection. The product, co-developed by Momenta ...

Fondaparinux sodium, a synthetic pentasaccharide ... a significantly lower overall rate of VTE with fondaparinux versus enoxaparin (6.8% versus 13.7%, p < 0.001). [3] A summary of studies that ...

Recent data have shown that fondaparinux, a selective factor Xa inhibitor, is noninferior to enoxaparin for short-term prevention of adverse cardiovascular outcomes in patients with non-ST-segment ...